We hypothesized that the recruitment of CD8+ T cells and the decrease of PD-L1 expression in tumor cells resulted in a decline of depleted CD8+ T cells and increased active CD8+ T cells, potentially enhancing the tumoricidal efficacy of CD8+ T cells. Here, CD8A is linked to neoplasm.